• Aller au contenu
• Aller à la navigation
• Aller à la recherche

Passer les liens principaux

• 
  • What's new?
  • Vision, Mission & Values
  • History
  • Structure
  • Quality, Safety & Environment
  • EDQM Library
  • Visit the EDQM
  • Contact the EDQM
• 
  • News and General Information
  • Blood Transfusion
    • Background & Mission
    • Organisation & Work Programme
    • Reports
    • Recommendations & Resolutions
    • Projects
    • World Blood Donor Day
  • Organ Transplantation
    • Background & Mission
    • Organisation & Work Programme
    • Reports
    • Recommendations & Resolutions
    • Projects
    • European Day for Organ Donation and Transplantation
  • Pharmaceutical Care
    • Pharmaceuticals & Pharmaceutical Care
    • Classification of Medicines as Regards their Supply
    • Quality and Safety Standards in Pharmaceutical Practices & Pharmaceutical Care
    • Counterfeit Medicines
• 
  • News and General Information
  • European Pharmacopoeia
    • Background & Legal Framework
    • Mission
    • Membership & Observership
    • Elaborations & Revisions
    • Participate in the Work of the Ph. Eur.
    • Work Programme
    • International Harmonisation
  • Reference Standards
    • Ph. Eur. Reference Standards
    • WHO International Standards for Antibiotics (ISA)
    • WHO International Chemical Reference Substances (ICRS)
  • Biological Standardisation Programme (BSP)
    • Background & Mission
    • The Steering Committee
    • Participate in a BSP Study
    • Work Programme
• 
  • News and General Information
  • General European OMCL Network
  • Gene Therapy
  • Proficiency Testing Scheme (PTS)
  • Quality Management (QM) Programme
  • Market Surveillance Studies (MSS)
  • Human Biologicals (OCABR)
  • Veterinary Biologicals (OCABR/OBPR)
  • CAP Sampling & Testing Programme
  • MRP/DCP Post Marketing Surveillance Scheme
  • Quality Monitoring of Stockpiled Medicines
  • Testing of counterfeit / illegal medicines within the GEON
• 
  • News and General Information
  • Background & Legal Framework
  • Mission & Organisation
  • New Applications
  • Revisions & Renewals
  • Technical Advice & One-to-One Meetings
  • The Inspection Programme
• 
  • Publications
    • European Pharmacopoeia
    • Pharmeuropa, Pharmeuropa Bio & Scientific Notes
    • Standard Terms
    • Blood Transfusion & Organ Transplantation Guides
    • Proceedings of International Conferences
    • Technical Guides
    • Product Specific Guidelines / Model Protocol Templates (OCABR/OBPR)
    • Quality Management (QM) Guidelines
  • Reference Standards
    • EDQM Reference Standards
    • WHO International Standards for Antibiotics (ISA)
    • WHO International Chemical Reference Substances (ICRS)
  • CombiStats
  • Proficiency Testing Scheme (PTS)
  • Certificates of Suitability

Aller aux liens principaux

Homepage / The European Pharmacopoeia / European Pharmacopoeia / Elaborations & Revisions

Elaborations & Revisions

Elaborations

The principles for elaborating the general chapters and monographs of the European Pharmacopoeia are continually adapted to keep pace with the regulatory needs of licensing, control and inspection authorities in the public health area, and with industrial constraints and technological and scientific advances. Under the P4 procedure, the European Pharmacopoeia Commission has decided to schedule its work on active substances so that monographs are produced a few years before the patent expiry date, thus making it possible to assess dossiers on generics on the basis of existing monographs and related Certificates of Suitability of the Monographs of the European Pharmacopoeia.

The European Pharmacopoeia Commission allocates the work to specially constituted groups of experts and working parties. The member of these groups come from regulatory authorities, official medicines control laboratories, pharmaceutical and chemical manufacturers, universities and research institutions. All monographs are verified experimentally and submitted to public consultation before inclusion in the European Pharmacopoeia.

Revisions

The texts are updated regularly taking into account changes in marketed products and scientific progress. Three types of revision take place:

• systematic revisions updating the most obsolete monographs

• revisions harmonising monographs on similar substances

• revisions on a case-by-case basis to satisfy requests received by the European Pharmacopoeia Commission either from a public health authority or from industry associations. Such requests are made when the monograph is found to be unsatisfactory in some respects or when the manufacturing method for marketed substances has been changed.